Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | SRRA | BCRX | AVDL | ||
Company | Sierra Oncology Inc | Biocryst Pharma Inc | Avadel Pharmaceuticals Plc ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 54.98 | 6.66 | 14.04 | ||
High | 55.17 | 6.82 | 14.27 | ||
Low | 54.98 | 6.54 | 13.78 | ||
Last | 54.99 | 6.55 | 13.89 | ||
Change | +0.02 | -0.12 | -0.23 | ||
% Change | +0.04% | -1.80% | -1.63% | ||
Volume | 862,800 | 2,712,200 | 805,700 | ||
20-Day Average Volume | 396,690 | 3,661,080 | 1,956,925 | ||
Previous Close | 54.97 | 6.67 | 14.12 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 54.91 | 6.34 | 14.95 | ||
20-Day Raw Stochastic | 62.96% | 64.29% | 17.87% | ||
20-Day Relative Strength | 77.35% | 57.04% | 34.48% | ||
Weighted Alpha | +89.10 | +2.91 | -6.62 | ||
Today's Opinion | 100% Buy | 88% Buy | 24% Sell | ||
Previous Opinion | 100% Buy | 88% Buy | 16% Sell | ||
Last Month's Opinion | 100% Buy | 40% Buy | 40% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.07% since 06/23/22 | +7.73% since 06/25/24 | -2.80% since 06/25/24 | ||
Low | 54.65 on 06/24/22 | 6.00 on 06/26/24 | 13.42 on 06/28/24 | ||
High | 55.19 on 06/24/22 | 6.82 on 07/02/24 | 14.74 on 06/28/24 | ||
1-Month | |||||
%Chg | +0.38% since 05/27/22 | +1.39% since 05/31/24 | -12.92% since 05/31/24 | ||
Low | 54.58 on 05/31/22 | 5.92 on 06/20/24 | 13.42 on 06/28/24 | ||
High | 55.19 on 06/24/22 | 6.99 on 06/03/24 | 16.10 on 06/03/24 | ||
3-Month | |||||
%Chg | +69.83% since 03/30/22 | +39.66% since 04/02/24 | -15.36% since 04/02/24 | ||
Low | 30.87 on 03/31/22 | 4.03 on 04/25/24 | 13.42 on 06/28/24 | ||
High | 55.19 on 06/24/22 | 6.99 on 06/03/24 | 19.09 on 05/03/24 | ||
6-Month | |||||
%Chg | +144.40% since 12/30/21 | +7.91% since 01/02/24 | -2.73% since 01/02/24 | ||
Low | 14.91 on 01/24/22 | 4.03 on 04/25/24 | 11.82 on 03/04/24 | ||
High | 55.19 on 06/24/22 | 7.75 on 01/10/24 | 19.09 on 05/03/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,342,801 | 1,351,769 | 1,335,093 | ||
Shares Outstanding, K | 24,419 | 206,377 | 96,119 | ||
Annual Sales | 0 | 331,410,000 | 27,960,000 | ||
Annual Net Income | -94,660,000 | -226,540,000 | -160,280,000 | ||
Last Quarter Sales | 0 | 92,760,000 | 27,180,000 | ||
Last Quarter Net Income | -27,930,000 | -35,380,000 | -27,340,000 | ||
60-Month Beta | 0.01 | 1.88 | 1.53 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.33 on 05/06/22 | -0.17 on 05/06/24 | -0.30 on 05/08/24 | ||
Latest Earnings Date | 08/04/22 | 08/01/24 | 08/14/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |